Today: 1 May 2026
Adobe stock barely budges near $353 as Fed minutes loom — what ADBE investors watch next
30 December 2025
1 min read

Adobe stock barely budges near $353 as Fed minutes loom — what ADBE investors watch next

NEW YORK, December 30, 2025, 12:26 ET — Regular session

  • Adobe shares were little changed midday, up $0.12 at $353.28
  • Investors are focused on Fed meeting minutes due at 2 p.m. ET
  • Adobe’s next scheduled company catalyst is its March 12 earnings call

Adobe shares were little changed on Tuesday, trading near $353 as investors braced for the Federal Reserve’s latest policy meeting minutes later in the day.

The “minutes” — the detailed record of the Fed’s meeting — matter now because rate expectations can swing Treasury yields and, in turn, valuations for long-duration growth stocks such as software companies.

Minutes from the Fed’s Dec. 9-10 meeting are due at 2 p.m. ET, after policymakers cut rates by a quarter point (0.25 percentage point) to a 3.50%-3.75% range, a decision that drew three dissents.

U.S. stocks edged lower in what Reuters described as likely light-volume year-end trade, with the Dow, S&P 500 and Nasdaq each down modestly earlier in the session. “There might be a little bit more attention paid to the minutes given the several dissents in the December meeting,” Ross Mayfield, an investment strategy analyst at Baird, said. Reuters

Against that backdrop, Adobe (ADBE.O) was up $0.12, or 0.03%, at $353.28.

The Photoshop maker last updated investors on Dec. 10, when it forecast fiscal 2026 revenue of $25.90 billion to $26.10 billion and adjusted earnings per share of $23.30 to $23.50, both above Wall Street expectations, citing demand for its design tools and greater monetization of its AI offerings.

In the same update, Adobe said it would reshuffle some forecast and reporting segments starting in fiscal 2026 to emphasize subscription revenue by customer group and year-ending annual recurring revenue.

Adobe has also been trying to extend its reach through conversational AI platforms. It said earlier this month it would integrate Photoshop, Adobe Express and Acrobat into ChatGPT, letting users trigger image edits, graphic design and PDF tasks inside the OpenAI-owned chatbot.

For traders, the near-term debate is whether those AI features translate into durable subscription growth rather than one-off experimentation, as competition intensifies across creative and marketing software.

A key watch item is annual recurring revenue, or ARR — a subscription metric that captures the annual value of contracted recurring revenue. Updates on AI-driven conversions and pricing for generative features are likely to be central to sentiment into 2026.

The next scheduled company catalyst is Adobe’s first-quarter fiscal 2026 earnings call on March 12, according to the company’s investor relations calendar.

On Tuesday, Adobe traded between $350.10 and $355.24. In the short term, the $350 area is acting as a line in the sand for buyers, while $355 has capped gains so far.

Near-term direction may hinge on rates: the Fed minutes later Tuesday could set the tone for Treasury yields and high-multiple software stocks into the final session of 2025.

Stock Market Today

  • Nvidia Shares Drop Over 4% Amid Increasing AI Chip Competition from Google and Amazon
    April 30, 2026, 8:44 PM EDT. Nvidia (NVDA) stock fell over 4% on Thursday as investors reacted to growing competition in the AI chip market from tech giants Amazon (AMZN) and Google (GOOG, GOOGL). Amazon reported strong growth in its in-house chip unit, while Google announced plans to sell its custom Tensor Processing Units (TPUs) to select customers for data center installation. Nvidia's B300 server prices have nearly doubled in China due to a crackdown on chip smuggling. Despite concerns, Nvidia maintains confidence in its chip flexibility, a key advantage in the AI infrastructure sector. Meanwhile, Qualcomm (QCOM) surged 14%, and memory and storage stocks like Sandisk (SNDK), Western Digital (WDC), and Seagate (STX) also advanced amid rising data center costs noted by Microsoft and Meta.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX
Previous Story

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus
Next Story

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Go toTop